Clinical trial

Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART

NCT02249962

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-05-01

PhaseN/A

Study timeline

Study start (actual)2015-05-01Date precision: month

Registry last updated2021-03-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Infant Exposure to Efavirenzunresolved

Interventions

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

Ministry of Health, Malawicollaborator

University of North Carolinacollaborator

Lighthouse Trustcollaborator

Baylor College of Medicinecollaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02249962 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.